AInvest★★★★★3-DAY FREE
Catch pre-market movers with AI signals.
Claim Trial
THRD(Quitar la ciudad)
Third Harmonic Bio·NASDAQ
--
--(--)
Third Harmonic Bio (THRD) Financial Statements
Third Harmonic Bio (THRD) Cash Flow Statement
During Q1 2024, Third Harmonic Bio (THRD) generated -6.29M in cash flow from operating activities, -- from investing activities, and 49.00K from financing activities. Click to view the cash flow statement and track how funds are moving through the company.
Cash Flow
Q1,2022 | Q1,2023 | Q1,2024 | TTM |
|---|
Start Date | Jan 1, 2022 | Jan 1, 2023 | Jan 1, 2024 | -- |
End Date | Mar 31, 2022 | Mar 31, 2023 | Mar 31, 2024 | -- |
Fiscal Year-End | Dec 31 | Dec 31 | Dec 31 | -- |
Net Cash Flows from Operating Activities | -8.11M -- | -6.67M +17.72% | -6.29M +5.72% | -- -- |
Depreciation and Amortization | -- -- | 3.00K -- | 12.00K +300.00% | -- -- |
Change in Working Capital | -779.00K -- | -344.00K +55.84% | -846.00K -145.93% | -- -- |
Net Cash Flows from Financing Activities | -- -- | -- -- | 49.00K -- | -- -- |
Net Increase in Cash and Cash Equivalents | -8.11M -- | -6.67M +17.72% | -6.24M +6.46% | -- -- |
Cash and Cash Equivalents at Beginning of Period | 128.28M -- | 289.32M +125.54% | 269.52M -6.84% | -- -- |
Cash and Cash Equivalents at End of Period | 120.17M -- | 282.64M +135.21% | 263.28M -6.85% | -- -- |
You can ask Aime
No Data
